Predicting chemoresistance in human malignant glioma cells: The role of molecular genetic analyses

No abstract is available for this paper.

• Publication year

  1998

• Venue

  International Journal of Cancer

• Publication date

  1998-12-18

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/(SICI)1097-0215(19981218)79:6<640::AID-IJC15>3.0.CO;2-ZPMID 9842975
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Chemosensitivity of human malignant glioma: modulation by p53 gene transfer

  1998cited by this paper
• Predicting response to cancer chemotherapy: the role of p53

  1998cited by this paper
• BCL-2 family protein expression in human malignant glioma: a clinical-pathological correlative study.

  1998cited by this paper
• Genetic instability leads to loss of both p53 alleles in a human glioblastoma

  1998cited by this paper
• Adenovirus-mediated p16/CDKN2 gene transfer suppresses glioma invasion in vitro

  1997cited by this paper
• Topoisomerase‐I inhibitors for human malignant glioma: Differential modulation of p53, p21, bax and bcl‐2 expression and of CD95‐mediated apoptosis by camptothecin and β‐lapachone

  1997cited by this paper
• Association of EGFR Gene Amplification and CDKN2 (p16/MTS1) Gene Deletion in Glioblastoma Multiforme

  1997cited by this paper
• Functional analysis of wild-type and malignant glioma derived CDKN2Aβ alleles: Evidence for an RB-independent growth suppressive pathway

  1997cited by this paper
• Chemotherapy of human malignant glioma

  1997cited by this paper
• bcl-2 protein expression in astrocytomas in relation to patient survival and p53 gene status

  1997cited by this paper
• Immunohistochemical analysis of Bcl-2, Bcl-X, Mcl-1, and Bax in tumors of central and peripheral nervous system origin.

  1997cited by this paper
• Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours

  1996cited by this paper
• Effects of hypoxia on drug resistance phenotype and genotype in human glioma cell lines

  1996cited by this paper
• Amplification of the cyclin-dependent kinase 4 (CDK4) gene is associated with high cdk4 protein levels in glioblastoma multiforme

  1996cited by this paper
• Protooncogene bcl-2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation.

  1995cited by this paper
• Prognostic significance of p53 immunoreactivity in patients with glioma.

  1995cited by this paper
• Tumor suppressor p53 is a direct transcriptional activator of the human bax gene.

  1995cited by this paper
• A novel form of Epstein-Barr virus latency in normal B cells in vivo.

  1995cited by this paper
• Replacement of the p16/CDKN2 gene suppresses human glioma cell growth.

  1995cited by this paper
• Prognostic indicators in a range of astrocytic tumours: an immunohistochemical study with Ki-67 and p53 antibodies.

  1995cited by this paper
• Analysis of the p53 gene and its expression in human glioblastoma cells.

  1994cited by this paper
• Prognostic implications of p53 overexpression in supratentorial astrocytic tumors.

  1994cited by this paper
• The Relationship between TPS 3 Mutations and Overexpression of p 53 and Prognosis in Malignant Gliomas of Childhood '

  year unknowncited by this paper

• Replication-associated base excision repair/single-strand break repair regulates PARG inhibitor response via the PRMT1/PRMT5/ATR axis

  2025cites this paper
• Comparative analysis of the antiglioblastoma activity of adenosine A2A receptor and CK1δ blockers.

  2025cites this paper
• Unveiling the role of Ndrg1 gene on the oxidative stress induction behind the anticancer potential of styrylquinazoline derivatives

  2025cites this paper
• Chemotaxis Effects on the Vascular Tumor Growth: Phase-field Model and Simulations.

  2024cites this paper
• IMPDH Inhibition Decreases TERT Expression and Synergizes the Cytotoxic Effect of Chemotherapeutic Agents in Glioblastoma Cells

  2024cites this paper
• Targeted inhibition of the methyltransferase SETD8 synergizes with the Wee1 inhibitor adavosertib in restraining glioblastoma growth

  2023cites this paper
• The effect of conductive aligned fibers in an injectable hydrogel on nerve tissue regeneration.

  2023cites this paper
• Anticancer properties of complexes derived from bidentate ligands.

  2023cites this paper
• Exploiting nanopore sequencing for characterization and grading of IDH‐mutant gliomas

  2023cites this paper
• CHIKV strains Brazil (wt) and Ross (lab-adapted) differ with regard to cell host range and antiviral sensitivity and show CPE in human glioblastoma cell lines U138 and U251

  2022cites this paper
• Predicting anti-cancer drug combination responses with a temporal cell state network model

  2022cites this paper
• Different Approaches for the Profiling of Cancer Pathway-Related Genes in Glioblastoma Cells

  2022cites this paper
• CD95 gene deletion may reduce clonogenic growth and invasiveness of human glioblastoma cells in a CD95 ligand-independent manner

  2022cites this paper
• Illuminating the Dark: Highly Selective Inhibition of Serine/Threonine Kinase 17A with Pyrazolo[1,5-a]pyrimidine-Based Macrocycles.

  2022cites this paper
• Meta-analysis on reporting practices as a source of heterogeneity in in vitro cancer research

  2021cites this paper
• Endoglin and TGF-β signaling in glioblastoma

  2021cites this paper
• Camptothecin and analogs: role in anticancer activities

  2020cites this paper
• Synergistic growth inhibition mediated by dual PI3K/mTOR pathway targeting and genetic or direct pharmacological AKT inhibition in human glioblastoma models

  2020cites this paper
• Repurposing of idebenone as a potential anti-cancer agent.

  2019cites this paper
• Synthetic Cannabinoids Influence the Invasion of Glioblastoma Cell Lines in a Cell- and Receptor-Dependent Manner

  2019cites this paper
• How reliable are in vitro IC50 values? Values vary with cytotoxicity assays in human glioblastoma cells.

  2019cites this paper
• Epidermal growth factor receptor and ligand family expression and activity in glioblastoma

  2018cites this paper
• Sustained Delivery of Doxorubicin via Acetalated Dextran Scaffold Prevents Glioblastoma Recurrence after Surgical Resection.

  2018cites this paper
• Preparation of PEGylated liposomes incorporating lipophilic lomeguatrib derivatives for the sensitization of chemo-resistant gliomas.

  2018cites this paper
• Antitumor Activity of DLX1008, an Anti-VEGFA Antibody Fragment with Low Picomolar Affinity, in Human Glioma Models

  2018cites this paper
• ASA404, a vascular disrupting agent, as an experimental treatment approach for brain tumors

  2017cites this paper
• Biological Role and Therapeutic Targeting of TGF-β3 in Glioblastoma

  2017cites this paper
• Targeting CXCR4 with immuno-modified iron oxide nanoparticles for cancer treatment with magnetically-induced hyperthermia. An in vitro approach.

  2017cites this paper
• Anticancer activity against glioblastoma cell lines by compounds present in algae, alone and in combination with anticancer drugs

  2016cites this paper
• Artesunate enhances the therapeutic response of glioma cells to temozolomide by inhibition of homologous recombination and senescence

  2016cites this paper
• A Novel Small-Molecule Integrin Antagonist Inhibits Cells Adhesion Followed By Anoikis in Endothelial Cells - A Comparative Analysis with Cilengitide

  2016cites this paper
• Dinaciclib, a Cyclin-Dependent Kinase Inhibitor Promotes Proteasomal Degradation of Mcl-1 and Enhances ABT-737–Mediated Cell Death in Malignant Human Glioma Cell Lines

  2016cites this paper
• The role of the microenvironment in regulation of CSPG-driven invasive and non-invasive tumor growth in glioblastoma

  2015cites this paper
• The role of the microenvironment in regulation of CSPG-driven invasive and non-invasive tumor growth in glioblastoma

  2015cites this paper
• Cucurbitacin-I inhibits Aurora kinase A, Aurora kinase B and survivin, induces defects in cell cycle progression and promotes ABT-737-induced cell death in a caspase-independent manner in malignant human glioma cells

  2015cites this paper
• Dinaciclib, a CDK inhibitor promotes proteasomal degradation of Mcl-1 and enhances ABT-737 mediated cell death in malignant human glioma cell lines

  2015cites this paper
• Identification of a novel cell-penetrating peptide targeting human glioblastoma cell lines as a cancer-homing transporter.

  2015cites this paper
• Prognostic value of tumor suppressors in osteosarcoma before and after neoadjuvant chemotherapy

  2015cites this paper
• Distribution of the Phosphatidylinositol 3-Kinase Inhibitors Pictilisib (GDC-0941) and GNE-317 in U87 and GS2 Intracranial Glioblastoma Models—Assessment by Matrix-Assisted Laser Desorption Ionization Imaging

  2014cites this paper
• DMD057513 1110..1116

  2014cites this paper
• Differential regulation of TGF-β-induced, ALK-5-mediated VEGF release by SMAD2/3 versus SMAD1/5/8 signaling in glioblastoma.

  2014cites this paper
• In Vivo Imaging of Hypoxia Signaling Pathway in a Glioblastoma Mouse Model

  2014cites this paper
• Temozolomide Involves Caspase 3 Activity and Cleavage of Prevention of Irradiation-induced Glioma Cell Invasion by

  2013cites this paper
• Cytostasis and morphological changes induced by mifepristone in human metastatic cancer cells involve cytoskeletal filamentous actin reorganization and impairment of cell adhesion dynamics

  2013cites this paper
• Bortezomib‐induced sensitization of malignant human glioma cells to vorinostat‐induced apoptosis depends on reactive oxygen species production, mitochondrial dysfunction, Noxa upregulation, Mcl‐1 cleavage, and DNA damage

  2013cites this paper
• Topoisomerase degradation, DSB repair, p53 and IAPs in cancer cell resistance to camptothecin-like topoisomerase I inhibitors.

  2013cites this paper
• Integrin a 5 b 1 Plays a Critical Role in Resistance to Temozolomide by Interfering with the p53 Pathway in High-Grade Glioma

  2012cites this paper
• Integrin α5β1 plays a critical role in resistance to temozolomide by interfering with the p53 pathway in high-grade glioma.

  2012cites this paper
• Targeting the PI3K Pathway in the Brain—Efficacy of a PI3K Inhibitor Optimized to Cross the Blood–Brain Barrier

  2012cites this paper
• Monitoring the glioma tropism of bone marrow-derived progenitor cells by 2-photon laser scanning microscopy and positron emission tomography.

  2012cites this paper
• Fermented Mistletoe Extract as a Multimodal Antitumoral Agent in Gliomas

  2012cites this paper
• Decrease in Fas-induced apoptosis by the γ-secretase inhibitor is dependent on p75(NTR) in a glioblastoma cell line.

  2012cites this paper
• Molecular Genetic Pathology of Solid Tumors

  2011cites this paper
• Sensitivity to cisplatin in primary cell lines derived from human glioma correlates with levels of EGR-1 expression

  2011cites this paper
• β-Lapachone-Induced Apoptosis is Associated with Inhibition of Cyclooxygenase-2 Activity in Human Lung Cancer A549 Cells

  2011cites this paper
• Sensitivity to and functional effects of tricyclic agents on glioma: an immunohistochemical and in vitro study

  2011cites this paper
• Rad51 and BRCA2 - New Molecular Targets for Sensitizing Glioma Cells to Alkylating Anticancer Drugs

  2011cites this paper
• Artesunate Induces Oxidative DNA Damage, Sustained DNA Double-Strand Breaks, and the ATM/ATR Damage Response in Cancer Cells

  2011cites this paper
• Induction of programmed cell death by inhibition of AKT with the alkylphosphocholine perifosine in in vitro models of platinum sensitive and resistant ovarian cancers

  2011cites this paper
• Cancer esearch cular and Cellular Pathobiology R RBE 2 F 1 Pathway Regulates Autophagy

  2010cites this paper
• Gene expression profile in a glioma cell line resistant to cell death induced by the chimeric tumor suppressor-1 (CTS-1), a dominant-positive variant of p53--the role of NFkappaB.

  2010cites this paper
• α5β1 integrin antagonists reduce chemotherapy‐induced premature senescence and facilitate apoptosis in human glioblastoma cells

  2010cites this paper
• An ANOCEF genomic and transcriptomic microarray study of the response to radiotherapy or to alkylating first-line chemotherapy in glioblastoma patients

  2010cites this paper
• Tyrosine kinase inhibitor gefitinib enhances topotecan penetration of gliomas.

  2010cites this paper
• Designing, optimizing, and implementing high-throughput siRNA genomic screening with glioma cells for the discovery of survival genes and novel drug targets.

  2010cites this paper
• HDMX regulates p53 activity and confers chemoresistance to 3-bis(2-chloroethyl)-1-nitrosourea.

  2010influential citation
• GDF-15 Contributes to Proliferation and Immune Escape of Malignant Gliomas

  2010cites this paper
• Functional genomic analysis of glioblastoma multiforme through short interfering RNA screening: a paradigm for therapeutic development.

  2010cites this paper
• The RB-E2F1 pathway regulates autophagy.

  2010cites this paper
• Identification of Survival Genes in Human Glioblastoma Cells by Small Interfering RNA Screening

  2009cites this paper
• Tubulin inhibitor AEZS 112 inhibits the growth of experimental human ovarian and endometrial cancers irrespective of caspase inhibition.

  2009cites this paper
• Cilengitide modulates attachment and viability of human glioma cells, but not sensitivity to irradiation or temozolomide in vitro.

  2009cites this paper
• Identification of Survival Genes in Human Glioblastoma Cells Using siRNA Screening

  2009cites this paper
• The two-pore domain potassium channel TASK3 functionally impacts glioma cell death

  2008cites this paper
• A small molecule disruptor of Rb/Raf-1 interaction inhibits cell proliferation, angiogenesis, and growth of human tumor xenografts in nude mice.

  2008cites this paper
• Perifosine inhibits growth of human experimental endometrial cancers by blockade of AKT phosphorylation.

  2008cites this paper
• The topoisomerase II inhibitor, genistein, induces G2/M arrest and apoptosis in human malignant glioma cell lines.

  2008cites this paper
• The four‐and‐a‐half‐LIM protein 2 (FHL2) is overexpressed in gliomas and associated with oncogenic activities

  2008cites this paper
• Tumor therapy mediated by lentiviral expression of shBcl-2 and S-TRAIL.

  2007cites this paper
• Four cardiac hormones eliminate 4-fold more human glioblastoma cells than the green mamba snake peptide.

  2007cites this paper
• In vitro apoptotic induction of human glioblastoma cells by Fas ligand plus etoposide and in vivo antitumour activity of combined drugs in xenografted nude rats.

  2007cites this paper
• Aberrant methylation of p16 predicts candidates for 5-fluorouracil-based adjuvant therapy in gastric cancer patients

  2007cites this paper
• Modulation des Wachstums und der Bestrahlungs- und Chemosensitivität von humanen malignen Gliomzellen unter Azidose und Hypoxie

  2007cites this paper
• Malignant glioma cells counteract antitumor immune responses through expression of lectin-like transcript-1.

  2007cites this paper
• Apoptosis Pathways and Chemotherapy

  2006cites this paper
• Regeneration and tolerance factor: a novel mediator of glioblastoma-associated immunosuppression.

  2006cites this paper
• Down-regulation of beta1,4-galactosyltransferase V is a critical part of etoposide-induced apoptotic process and could be mediated by decreasing Sp1 levels in human glioma cells.

  2006cites this paper
• Mechanisms of Resistance of Human Glioma Cells to Apo2 Ligand/TNF-Related Apoptosis-Inducing Ligand

  2006cites this paper
• Role of p16 and p14ARF in radio- and chemosensitivity of malignant gliomas.

  2006cites this paper
• E2F1 identified by promoter and biochemical analysis as a central target of glioblastoma cell‐cycle arrest in response to ras inhibition

  2006influential citation
• O6‐methylguanine DNA methyltransferase and p53 status predict temozolomide sensitivity in human malignant glioma cells

  2006influential citation
• Down-regulation of β1,4-galactosyltransferase V is a critical part of etoposide-induced apoptotic process and could be mediated by decreasing Sp1 levels in human glioma cells

  2006cites this paper
• Sensitization of glioma cells to Fas-dependent apoptosis by chemotherapy-induced oxidative stress.

  2005cites this paper
• Multidrug Resistance-Proteine in humanen malignen Gliomen Expression, funktionelle Aktivität und Regulation durch p53

  2005cites this paper
• Effect of trichostatin A, a histone deacetylase inhibitor, on glioma proliferation in vitro by inducing cell cycle arrest and apoptosis.

  2005cites this paper
• Topotecan-triggered degradation of topoisomerase I is p53-dependent and impacts cell survival.

  2005cites this paper
• Prognostic signi cance of an apoptotic index and apoptosis / proliferation ratio for patients with high-grade astrocytomas 1

  2005cites this paper
• Gene expression profile induced by BCNU in human glioma cell lines with differential MGMT expression

  2005cites this paper
• Angiogenesis and apoptosis in glioma: Two arenas for promising new therapies

  2005cites this paper
• Death receptor-mediated apoptosis in human malignant glioma cells: modulation by the CD40/CD40L system.

  2005cites this paper